http://www.cnr.it/ontology/cnr/individuo/prodotto/ID215247
Comparative Efficacy and Safety of 3-Day Azithromycin and10-Day Penicillin V Treatment of Group A Beta-Hemolytic Streptococcal Pharyngitis in Children (Articolo in rivista)
- Type
- Label
- Comparative Efficacy and Safety of 3-Day Azithromycin and10-Day Penicillin V Treatment of Group A Beta-Hemolytic Streptococcal Pharyngitis in Children (Articolo in rivista) (literal)
- Anno
- 1996-01-01T00:00:00+01:00 (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
- 10.1097/00006454-199705000-00033 (literal)
- Alternative label
1)LUCIA PACIFICO;2) FRANCA SCOPETTI;1)ALESSANDRO RANUCCI;2) MARCO PATARACCHIA;1) FERDINANDO SAVIGNONI;3) CLAUDIO CHIESA (1996)
Comparative Efficacy and Safety of 3-Day Azithromycin and10-Day Penicillin V Treatment of Group A Beta-Hemolytic Streptococcal Pharyngitis in Children
in Antimicrobial agents and chemotherapy (Print); ASM, American society for microbiology, Washington, DC (Stati Uniti d'America)
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- 1)LUCIA PACIFICO;2) FRANCA SCOPETTI;1)ALESSANDRO RANUCCI;2) MARCO PATARACCHIA;1) FERDINANDO SAVIGNONI;3) CLAUDIO CHIESA (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
- Note
- ISI Web of Science (WOS) (literal)
- Scopu (literal)
- ubme (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- 1)Institute of Pediatrics, Sapienza University of Rome;
2)National Health Institute,Rome;
3)Institute of Experimental Medicine,National Research Council,Rome,Italy. (literal)
- Titolo
- Comparative Efficacy and Safety of 3-Day Azithromycin and10-Day Penicillin V Treatment of Group A Beta-Hemolytic Streptococcal Pharyngitis in Children (literal)
- Abstract
- The efficacy and safety of a 3-day course of azithromycin oral suspension (10 mg/kg of body weight once daily) were compared with those of penicillin V (50,000 U/kg/day in two divided doses) in children aged 3 to 12 years for the treatment of symptomatic pharyngitis caused by the group A beta-hemolytic streptococcus (GABHS). For the 154 evaluable patients, the original infecting strain of GABHS was eliminated at the end of follow-up (34 to 36 days after treatment started) from 67 (85.8%) of 78 penicillin-treated patients and 41 (53.9%) of 76 azithromycin-treated patients (P < 0.0001). Overall clinical success was achieved in 71 (91.0%) of 78 penicillin V-treated patients and 57 (75.0%) of 76 azithromycin-treated patients (P < 0.05). Potential drug-related adverse events were reported for 5.5 and 8.6% of the penicillin V- and azithromycin-treated patients, respectively (P = 0.6). In the present study, a once-daily (10 mg/kg), 3-day oral regimen of azithromycin was as safe as a 10-day course of penicillin but did not represent an effective alternative to penicillin for the treatment of GABHS pharyngitis, even for those children with azithromycin-susceptible strains. (literal)
- Editore
- Autore CNR
- Insieme di parole chiave
Incoming links:
- Autore CNR di
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Editore di
- Insieme di parole chiave di